N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

C21H25N11O — CID 176705767

IUPACN-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESNc1nn(C2CCC2)cc1NC(=O)c1cnn2ccc(C3=CN(N4CCCN4)CC=N3)nc12
InChIInChI=1S/C21H25N11O/c22-19-18(13-31(28-19)14-3-1-4-14)27-21(33)15-11-25-30-9-5-16(26-20(15)30)17-12-29(10-7-23-17)32-8-2-6-24-32/h5,7,9,11-14,24H,1-4,6,8,10H2,(H2,22,28)(H,27,33)
InChIKeyIYGMVZOGCIZMKJ-UHFFFAOYSA-N
MW447.51 g/mol
LogP1.30
Rot. Bonds5

About N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 176705767) has the molecular formula C21H25N11O and a molecular weight of 447.51 g/mol. Its IUPAC name is N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound NameN-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID176705767
Molecular FormulaC21H25N11O
Molecular Weight447.51 g/mol
Exact Mass447.22
IUPAC NameN-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESNc1nn(C2CCC2)cc1NC(=O)c1cnn2ccc(C3=CN(N4CCCN4)CC=N3)nc12
InChIInChI=1S/C21H25N11O/c22-19-18(13-31(28-19)14-3-1-4-14)27-21(33)15-11-25-30-9-5-16(26-20(15)30)17-12-29(10-7-23-17)32-8-2-6-24-32/h5,7,9,11-14,24H,1-4,6,8,10H2,(H2,22,28)(H,27,33)
InChIKeyIYGMVZOGCIZMKJ-UHFFFAOYSA-N
XLogP1.30
TPSA134.00 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500447.51
LogP ≤ 51.30
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Analyze N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 176705767) is N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide is Nc1nn(C2CCC2)cc1NC(=O)c1cnn2ccc(C3=CN(N4CCCN4)CC=N3)nc12.
What is the InChIKey of N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is IYGMVZOGCIZMKJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H25N11O/c22-19-18(13-31(28-19)14-3-1-4-14)27-21(33)15-11-25-30-9-5-16(26-20(15)30)17-12-29(10-7-23-17)32-8-2-6-24-32/h5,7,9,11-14,24H,1-4,6,8,10H2,(H2,22,28)(H,27,33).
What are the key properties of N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 447.51 g/mol, XLogP of 1.30, 5 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-amino-1-cyclobutylpyrazol-4-yl)-5-(1-pyrazolidin-1-yl-2H-pyrazin-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 176705767), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).